These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11136502)

  • 1. Should all trials have a data safety and monitoring committee?
    Cairns JA; Hallstrom A; Held P
    Am Heart J; 2001 Jan; 141(1):156-63. PubMed ID: 11136502
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Workshop on Data Monitoring Committee in NIH"--data monitoring in cancer clinical trial].
    Sakamoto J; Nakazato H
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1099-104. PubMed ID: 1626947
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monitoring of clinical trials and interim analysis. 1. Monitoring committee].
    Boutitie F; Bellissant E; Blanchard J; Boissel JP; Cauquil J; Chauvin F; Derzko G; Ducruet T; Durrleman S; Girre JP
    Therapie; 1992; 47(4):345-9. PubMed ID: 1494799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pharmacological committee yesterday, today and tomorrow].
    Lepakhin VK
    Ter Arkh; 1990; 62(9):4-7. PubMed ID: 2281404
    [No Abstract]   [Full Text] [Related]  

  • 5. Data and safety monitoring committees: philosophy and practice.
    Califf RM; Lee KL
    Am Heart J; 2001 Jan; 141(1):154-5. PubMed ID: 11136501
    [No Abstract]   [Full Text] [Related]  

  • 6. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation).
    McNamara RL; Brass LM; Drozda JP; Go AS; Halperin JL; Kerr CR; Lévy S; Malenka DJ; Mittal S; Pelosi F; Rosenberg Y; Stryer D; Wyse DG; Radford MJ; Goff DC; Grover FL; Heidenreich PA; Malenka DJ; Peterson ED; Redberg RF; ; ;
    Circulation; 2004 Jun; 109(25):3223-43. PubMed ID: 15226233
    [No Abstract]   [Full Text] [Related]  

  • 7. [The quality of compliance of case record forms in clinical trials].
    Vidal V
    Med Clin (Barc); 1993 Feb; 100(5):197-8. PubMed ID: 8450703
    [No Abstract]   [Full Text] [Related]  

  • 8. [The drug commission of German physicians and phase IV screening].
    Ochsenfahrt H
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):929-32. PubMed ID: 6417498
    [No Abstract]   [Full Text] [Related]  

  • 9. [Steering committees in drug trials].
    Kleinsorge H
    Med Monatsschr Pharm; 1997 Feb; 20(2):29. PubMed ID: 9132534
    [No Abstract]   [Full Text] [Related]  

  • 10. Fumes from the spleen.
    Paediatr Perinat Epidemiol; 1997 Apr; 11(2):136-8. PubMed ID: 9131705
    [No Abstract]   [Full Text] [Related]  

  • 11. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Commitee to Develop Data Standards on Atrial Fibrillation).
    McNamara RL; Brass LM; Drozda JP; Go AS; Halperin JL; Kerr CR; Lévy S; Malenka DJ; Mittal S; Pelosi F; Rosenberg Y; Stryer D; Wyse DG; Radford MJ; Goff DC; Grover FL; Heidenreich PA; Malenka DJ; Peterson ED; Redberg RF; ;
    J Am Coll Cardiol; 2004 Jul; 44(2):475-95. PubMed ID: 15261958
    [No Abstract]   [Full Text] [Related]  

  • 12. Early stopping of clinical trials.
    Cuzick J; Howell A; Forbes J
    Breast Cancer Res; 2005; 7(5):181-3. PubMed ID: 16168134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA issues guidance on race and ethnicity data.
    Meadows M
    FDA Consum; 2003; 37(3):36. PubMed ID: 12793392
    [No Abstract]   [Full Text] [Related]  

  • 14. Survey of P&T committee members: glaucoma agents gaining notice.
    Manag Care; 2002 Nov; 11(11 Suppl):58-60. PubMed ID: 15357541
    [No Abstract]   [Full Text] [Related]  

  • 15. ITT in respect to GCP: a matter of diligence.
    Van der Weijden F; Slot DE; Rosema M; Timmerman M
    J Clin Periodontol; 2008 Aug; 35(8):681-2. PubMed ID: 18727741
    [No Abstract]   [Full Text] [Related]  

  • 16. The investigational drug steering committee.
    Ratain MJ
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):779-80. PubMed ID: 17998895
    [No Abstract]   [Full Text] [Related]  

  • 17. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of drug and therapeutics committee towards drug safety--experiences from western Nepal.
    Palaian S; Mishra P
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):79-80. PubMed ID: 16401950
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug trials. Reform or modification of the current system].
    Lemaire A
    Nouv Presse Med; 1975 May; 4(18):1367-71. PubMed ID: 1098017
    [No Abstract]   [Full Text] [Related]  

  • 20. Committee for Medicinal Products for Human Use (CHMP) guideline on Data Monitoring Committees.
    ; ;
    Stat Med; 2006 May; 25(10):1639-45. PubMed ID: 16639775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.